Statins inhibit leukocyte recruitment: New evidence for their anti-inflammatory properties

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 8, 2001, Pages 1256-1258

  Kwak, Brenda R ^a   Mach, Francois ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b WHO Collaborating Centre in Education and Research in Human Reproduction   (Switzerland)

Author keywords

Editorials; Inflammation; Leukocytes; Statins

Indexed keywords

ANTIINFLAMMATORY AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; MEVINOLIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SIMVASTATIN; STATINE;

ATHEROGENESIS; ATHEROSCLEROSIS; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; HEMODYNAMICS; HUMAN; INFLAMMATION; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035573665     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/atvb.21.8.1256     Document Type: Editorial

References (31)

1. The global burden of disease, 1990-2020
2. Atherosclerosis: An inflammatory disease
3. Atherosclerosis: The road ahead
4. Atherosclerosis
5. Changing concepts of atherogenesis
6. Current perspectives on statins
7. Protein lipidation in cell signaling
8. Statins do more than just lower cholesterol
9. Non-lipid-related effects of statins
10. Low-density lipoprotein-independent effects of statins
11. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
12. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase
13. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
14. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1)
15. HMG CoA reductase inhibitors: In vivo effects on carotid intimal thickening in normocholesterolemic rabbits
16. 3-Hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture
17. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells: Role of geranylgeranylation and Rho proteins
18. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma
19. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization
20. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits
21. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia
22. Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s)
23. Inhibition of monocyte chemotactic protein-1 synthesis by statins
24. Statins as a newly recognized type of immunomodulator
25. The HMG-CoA reductase inhibitor simvastatin inhibits IFN-γ induced MHC class II expression in human vascular endothelial cells
26. Immunomodulation: A new role for statins?
27. The in vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products
28. HMG-CoA reductase inhibitor modulates monocyte endothelial interaction under physiological flow condition in vitro: Involvement of Rho GTPase-dependent mechanism
29. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering
30. Monocyte adhesion and spreading on human endothelial cells is dependent on Rho-regulated receptor clustering
31. A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: The role of mevalonic acid